세계의 나노의학 약물 전달 시장 보고서(2025년)

Nanomedicine drug delivery involves the use of nanoscale materials and technologies to transport therapeutic agents directly to specific targets within the body. This approach enhances treatment precision and control, ensuring optimal interaction with disease sites. Nanomedicine drug delivery improves drug stability, absorption, and bioavailability, resulting in more effective therapeutic outcomes. Its key benefit is the reduction of systemic exposure while maximizing the therapeutic effect.

The primary product types of nanomedicine drug delivery include nanoparticles, liposomes, micelles, dendrimers, nanotubes, and others. Nanoparticles serve as nanoscale carriers that deliver therapeutic agents directly to targeted cells or tissues, improving drug efficacy and reducing side effects. These drug delivery systems can be administered through various routes such as oral, injectable, topical, and others. They are used in several therapeutic areas, including oncology, cardiovascular diseases, neurology, infectious diseases, and others, and are employed by end users such as hospitals, clinics, research institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The nanomedicine drug delivery market research report is one of a series of new reports from The Business Research Company that provides nanomedicine drug delivery market statistics, including nanomedicine drug delivery industry global market size, regional shares, competitors with a nanomedicine drug delivery market share, detailed nanomedicine drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine drug delivery industry. The nanomedicine drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nanomedicine drug delivery market size has grown rapidly in recent years. It will grow from $106.51 billion in 2024 to $123.37 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. Growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising demand for targeted therapies, growing global healthcare expenditure, greater investment in pharmaceutical infrastructure, expansion of nanomedicine applications in oncology, and rising awareness of personalized treatment approaches.

The nanomedicine drug delivery market size is expected to see rapid growth in the next few years. It will grow to $219.30 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth during the forecast period can be attributed to the rising global aging population, the increasing prevalence of cardiovascular and neurological disorders, the growing emphasis on precision medicine initiatives, the rise in government support for nanomedicine research, the development of healthcare infrastructure in emerging regions, and the strengthening collaborations between pharmaceutical and research organizations. Key trends in the forecast period include progress in nanoparticle-based drug carriers, improvements in stimuli-responsive nanocarriers, innovations in multifunctional nanomedicine platforms, advancements in nanoscale drug delivery for overcoming biological barriers, research and development in personalized nanotherapeutics, and progress in hybrid nanocarrier systems for controlled release.

The increasing adoption of personalized medicine is expected to drive the growth of the nanomedicine drug delivery market in the coming years. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to the unique characteristics of each patient, such as genetic profile or disease subtype. The adoption of personalized medicine is rising as advances in genomics and molecular science enable treatments customized to an individual's genetic makeup, improving effectiveness and supporting precise, targeted care. Nanomedicine drug delivery complements personalized medicine by accurately directing drugs to target cells and adjusting dosages and formulations for each patient, improving therapeutic outcomes and minimizing side effects. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based international non-profit organization, the United States Food and Drug Administration approved sixteen new personalized treatments for patients with rare diseases in 2023, up from six approvals in 2022. Therefore, the increasing adoption of personalized medicine is propelling the growth of the nanomedicine drug delivery market.

Leading companies operating in the nanomedicine drug delivery market are focusing on developing advanced drug delivery solutions, such as AI-powered nano-delivery platforms, to enhance targeting precision and accelerate the development of personalized therapies. AI-powered nano-delivery platforms are advanced systems that use artificial intelligence to design and optimize nanoparticles for accurate drug targeting, improving therapeutic performance, minimizing adverse effects, and supporting individualized treatment approaches. For instance, in September 2025, METiS TechBio, a China-based biotechnology company, introduced NanoForge, an AI-driven nano-delivery platform aimed at transforming medicine development and delivery. The system combines artificial intelligence with nanotechnology to optimize lipid nanoparticle formulations and deliver drugs directly to target tissues, enabling faster, safer, and more cost-effective drug development. This innovation is designed to address major challenges in drug delivery for complex molecules such as mRNA, advancing the field toward programmable and adaptive therapeutics.

In July 2024, ME Therapeutics Inc., a Canada-based preclinical-stage immuno-oncology company, entered into a partnership with NanoVation Therapeutics Inc. to develop advanced messenger ribonucleic acid (mRNA) delivery systems aimed at targeting myeloid cells for cancer treatment. Through this collaboration, ME Therapeutics seeks to utilize NanoVation's proprietary long-circulating lipid nanoparticle platform to improve the precision, efficacy, and in vivo targeting of mRNA therapeutics, accelerating the development of new treatments in the nanomedicine drug delivery sector. NanoVation Therapeutics Inc. is a Canada-based biotechnology company specializing in the design and development of lipid nanoparticle technologies for nucleic acid delivery.

Major players in the nanomedicine drug delivery market are Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Evonik Industries AG, Ipsen Pharma S.A.S., Pacira BioSciences Inc., Camurus AB, Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Acuitas Therapeutics Inc., NanoViricides Inc., Taiwan Liposome Company Ltd., Aphios Corporation, Concept Medical Inc., DelSiTech Ltd., ANP Technologies Inc., ProMab Biotechnologies Inc., BlueWillow Biologics Inc., and Nanoform Finland Plc.

North America was the largest region in the nanomedicine drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomedicine drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nanomedicine drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanomedicine drug delivery market consists of revenues earned by entities by providing services such as drug formulation services, nanocarrier design services, clinical trial management services, regulatory consulting services, contract research services, and contract manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanomedicine drug delivery market also includes sales of nanocarrier-based drug formulations, targeted drug delivery systems, sustained release nanomedicines, polymeric nanoparticles, lipid-based nanocarriers, and nanoemulsions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanomedicine Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanomedicine drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanomedicine drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanomedicine drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Nanoparticles; Liposomes; Micelles; Dendrimers; Nanotubes; Other Product Types
• 2) By Route Of Administration: Oral; Injectable; Topical; Other Routes Of Administration
• 3) By Application: Oncology; Cardiovascular Diseases; Neurology; Infectious Diseases; Other Applications
• 4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Nanoparticles: Polymeric Nanoparticles; Metallic Nanoparticles; Lipid-Based Nanoparticles; Magnetic Nanoparticles; Quantum Dots
• 2) By Liposomes: Conventional Liposomes; Stealth Liposomes; Cationic Liposomes; Anionic Liposomes; pH-Sensitive Liposomes
• 3) By Micelles: Polymeric Micelles; Lipid Micelles; Amphiphilic Block Copolymer Micelles; Stimuli-Responsive Micelles; Mixed Micelles
• 4) By Dendrimers: Polyamidoamine Dendrimers; Polypropylene Imine Dendrimers; Peptide Dendrimers; Carbohydrate Dendrimers; Hydroxyl-Terminated Dendrimers
• 5) By Nanotubes: Carbon Nanotubes; Peptide Nanotubes; Inorganic Nanotubes; Multi-Walled Nanotubes; Single-Walled Nanotubes
• 6) By Other Product Types: Nanospheres; Nanocapsules; Nanoemulsions; Nanogels; Hybrid Nanocarrier
• Companies Mentioned: Pfizer Inc.; Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc.; Evonik Industries AG; Ipsen Pharma S.A.S.; Pacira BioSciences Inc.; Camurus AB; Arcturus Therapeutics Holdings Inc.; Nanobiotix S.A.; Acuitas Therapeutics Inc.; NanoViricides Inc.; Taiwan Liposome Company Ltd.; Aphios Corporation; Concept Medical Inc.; DelSiTech Ltd.; ANP Technologies Inc.; ProMab Biotechnologies Inc.; BlueWillow Biologics Inc.; Nanoform Finland Plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nanomedicine Drug Delivery Market Characteristics

3. Nanomedicine Drug Delivery Market Trends And Strategies

4. Nanomedicine Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nanomedicine Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nanomedicine Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nanomedicine Drug Delivery Market Growth Rate Analysis
• 5.4. Global Nanomedicine Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nanomedicine Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nanomedicine Drug Delivery Total Addressable Market (TAM)

6. Nanomedicine Drug Delivery Market Segmentation

• 6.1. Global Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticles
• Liposomes
• Micelles
• Dendrimers
• Nanotubes
• Other Product Types
• 6.2. Global Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• Other Routes Of Administration
• 6.3. Global Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Other Applications
• 6.4. Global Nanomedicine Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutes
• Other End-Users
• 6.5. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Nanoparticles
• Metallic Nanoparticles
• Lipid-Based Nanoparticles
• Magnetic Nanoparticles
• Quantum Dots
• 6.6. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Liposomes
• Stealth Liposomes
• Cationic Liposomes
• Anionic Liposomes
• pH-Sensitive Liposomes
• 6.7. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Micelles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Micelles
• Lipid Micelles
• Amphiphilic Block Copolymer Micelles
• Stimuli-Responsive Micelles
• Mixed Micelles
• 6.8. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polyamidoamine Dendrimers
• Polypropylene Imine Dendrimers
• Peptide Dendrimers
• Carbohydrate Dendrimers
• Hydroxyl-Terminated Dendrimers
• 6.9. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Nanotubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbon Nanotubes
• Peptide Nanotubes
• Inorganic Nanotubes
• Multi-Walled Nanotubes
• Single-Walled Nanotubes
• 6.10. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanospheres
• Nanocapsules
• Nanoemulsions
• Nanogels
• Hybrid Nanocarriers

7. Nanomedicine Drug Delivery Market Regional And Country Analysis

• 7.1. Global Nanomedicine Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nanomedicine Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanomedicine Drug Delivery Market

• 8.1. Asia-Pacific Nanomedicine Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanomedicine Drug Delivery Market

• 9.1. China Nanomedicine Drug Delivery Market Overview
• 9.2. China Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanomedicine Drug Delivery Market

• 10.1. India Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanomedicine Drug Delivery Market

• 11.1. Japan Nanomedicine Drug Delivery Market Overview
• 11.2. Japan Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanomedicine Drug Delivery Market

• 12.1. Australia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanomedicine Drug Delivery Market

• 13.1. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanomedicine Drug Delivery Market

• 14.1. South Korea Nanomedicine Drug Delivery Market Overview
• 14.2. South Korea Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanomedicine Drug Delivery Market

• 15.1. Western Europe Nanomedicine Drug Delivery Market Overview
• 15.2. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanomedicine Drug Delivery Market

• 16.1. UK Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanomedicine Drug Delivery Market

• 17.1. Germany Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanomedicine Drug Delivery Market

• 18.1. France Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanomedicine Drug Delivery Market

• 19.1. Italy Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanomedicine Drug Delivery Market

• 20.1. Spain Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanomedicine Drug Delivery Market

• 21.1. Eastern Europe Nanomedicine Drug Delivery Market Overview
• 21.2. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanomedicine Drug Delivery Market

• 22.1. Russia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanomedicine Drug Delivery Market

• 23.1. North America Nanomedicine Drug Delivery Market Overview
• 23.2. North America Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanomedicine Drug Delivery Market

• 24.1. USA Nanomedicine Drug Delivery Market Overview
• 24.2. USA Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanomedicine Drug Delivery Market

• 25.1. Canada Nanomedicine Drug Delivery Market Overview
• 25.2. Canada Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanomedicine Drug Delivery Market

• 26.1. South America Nanomedicine Drug Delivery Market Overview
• 26.2. South America Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanomedicine Drug Delivery Market

• 27.1. Brazil Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanomedicine Drug Delivery Market

• 28.1. Middle East Nanomedicine Drug Delivery Market Overview
• 28.2. Middle East Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanomedicine Drug Delivery Market

• 29.1. Africa Nanomedicine Drug Delivery Market Overview
• 29.2. Africa Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanomedicine Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Nanomedicine Drug Delivery Market Competitive Landscape
• 30.2. Nanomedicine Drug Delivery Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

31. Nanomedicine Drug Delivery Market Other Major And Innovative Companies

• 31.1. Ipsen Pharma S.A.S.
• 31.2. Pacira BioSciences Inc.
• 31.3. Camurus AB
• 31.4. Arcturus Therapeutics Holdings Inc.
• 31.5. Nanobiotix S.A.
• 31.6. Acuitas Therapeutics Inc.
• 31.7. NanoViricides Inc.
• 31.8. Taiwan Liposome Company Ltd.
• 31.9. Aphios Corporation
• 31.10. Concept Medical Inc.
• 31.11. DelSiTech Ltd.
• 31.12. ANP Technologies Inc.
• 31.13. ProMab Biotechnologies Inc.
• 31.14. BlueWillow Biologics Inc.
• 31.15. Nanoform Finland Plc

32. Global Nanomedicine Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanomedicine Drug Delivery Market

34. Recent Developments In The Nanomedicine Drug Delivery Market

35. Nanomedicine Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Nanomedicine Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nanomedicine Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nanomedicine Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer